Jeffrey Alvaro
Child & Adolescent Psychiatry · St Petersburg, FLNPI 1124079108
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $66,193 of the $86,698 with a category attached, or 76.3%. 19 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 36.0% of the total. 2025 is the largest year on record at $31,496, 2.6 times the $12,171 reported in 2019. Among child & adolescent psychiatry clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 171 payments — averaging $507.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$31K
- Supernus Pharmaceuticals, Inc.$28K
- Corium, LLC$12K
- Ironshore Pharmaceuticals Inc.$9K
- Neos Therapeutics, LP$2K
- AbbVie$893
- plus $3K from 13 others
What the payments were for
- Consulting fees$3,8004%
- Speaking & faculty fees$66,19376%
- Travel & lodging$7,8719%
- Food & beverage$8,83510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 27 | $31,173 |
| Supernus Pharmaceuticals, Inc. | 57 | $27,995 |
| Corium, LLC | 13 | $11,934 |
| Ironshore Pharmaceuticals Inc. | 34 | $9,309 |
| Neos Therapeutics, LP | 7 | $2,480 |
| AbbVie(2 entities) | 8 | $893 |
| Teva Pharmaceuticals USA, Inc. | 6 | $698 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $457 |
| Tris Pharma Inc | 3 | $324 |
| Otsuka America Pharmaceutical, Inc. | 2 | $236 |
| Sunovion Pharmaceuticals Inc. | 2 | $234 |
| Jazz Pharmaceuticals Inc. | 2 | $190 |
| Idorsia Pharmaceuticals US Inc | 1 | $124 |
| Eisai Inc. | 1 | $124 |
| Axsome Therapeutics, Inc. | 1 | $118 |
| Neurocrine Biosciences, Inc. | 1 | $115 |
| Alkermes, Inc. | 1 | $110 |
| Neuronetics, Inc. | 1 | $93 |
| Johnson & Johnson | 1 | $91 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JORNAY PM$31,358
- QELBREE$19,840
- Azstarys$11,934
- Jornay PM 20mg capsules (Bottle of 100)$8,111
- Adzenys XR-ODT$2,271
- Cotempla XR-ODT$2,269
- VRAYLAR$701
- AUSTEDO$586
- CAPLYTA$457
- LYBALVI$442
- REXULTI$236
- LATUDA$234
- SUNOSI$224
- Dyanavel XR$125
- QUVIVIQ$124
- Dayvigo$124
- INGREZZA$115
- Austedo XR$113
- Onyda XR$104
How this compares
$86,698 in reported general payments places this provider in the 95th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Other child & adolescent psychiatry in St Petersburg
- Craig KuninsGulfport$265K
- Elias SarkisGainesville$169K
- Rosa Negron MunozLakeland$39K
- Sean HoranMiami$17K
- Rachel AgustinesLargo$16K
- Carlos BorgeSarasota$15K
- Justin SpoonerPonte Vedra Beach$12K
- Bhaskar RajuOrlando$11K
- Americo PadillaMiami$11K
- Marcos CintronHialeah$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.